* INSYS THERAPEUTICS - ONGOING DIALOGUE WITH DOJ HAS NOT RESULTED IN INFORMATION THAT WOULD CAUSE CO TO REVISE ESTIMATE OF MINIMUM LIABILITY EXPOSURE

* INSYS THERAPEUTICS SAYS CONTINUES TO HAVE ONGOING DIALOGUE WITH U.S. DOJ REGARDING INVESTIGATION THAT IN DEC 2013 WAS COMMENCED BY DOJ’S CIVIL DIVISION Source text for Eikon: Further company coverage: